Abstract
Marketing defective breast implants (BellaGel®; HansBiomed Co. Ltd., Seoul, Korea) despite knowledge or reasonable cause to believe that the device is defective has been recently found in Korea, thus termed as the BellaGel® breast implant scandal. Evidence suggests that the HansBiomed Co. Ltd. previously participated in the Poly Implant Prothèse (PIP) fraud in Europe. Based on the fact that the manufacturer was previously involved in the PIP fraud, it would be mandatory to consider long-term safety outcomes of victims of the BellaGel® breast implant scandal.
Cite
CITATION STYLE
JH, K. (2021). Association of the BellaGel® Breast Implant Scandal with the Poly Implant Prothèse Fraud: A Review of Literatures. Journal of Surgery: Open Access, 7(1). https://doi.org/10.16966/2470-0991.230
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.